1. EachPod

AudioAbstracts - Podcast

AudioAbstracts

AudioAbstracts by ReachMD provides an easy-to-digest distillation of important medical literature in combination with digital linkage to in-depth information supporting the audio synopsis. AudioAbstracts harnesses the ReachMD digital network to broadcast the spoken synopsis and related digital links through its on-air, online, onsite, and mobile distribution network. Combining quick-read audio synopses with links to source material, AudioAbstracts is the smarter, faster way to stay current on medical literature.

Science & Medicine Medicine Health
Update frequency
every 71 days
Episodes
48
Years Active
2015 - 2025
Share to:
Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by MR Enterography

Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by MR Enterography

Guest: Yash Mittal, MD

Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by Magnetic Resonance Enterography.

Vipul Jairath, MD, PhD, Ingrid Ordas, MD, PhD, Guangyong…

Tue 29 Jan 2019
Success of Adalimumab Dose Escalation & De-Escalation in Ulcerative Colitis

Success of Adalimumab Dose Escalation & De-Escalation in Ulcerative Colitis

Guest: Shail M. Govani, MD, MSc

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study.

Saartje Van de …

Tue 29 Jan 2019
Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by MR Enterography

Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by MR Enterography

Guest: Yash Mittal, MD

Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by Magnetic Resonance Enterography.

Vipul Jairath, MD, PhD, Ingrid Ordas, MD, PhD, Guangyong…

Tue 29 Jan 2019
Success of Adalimumab Dose Escalation & De-Escalation in Ulcerative Colitis

Success of Adalimumab Dose Escalation & De-Escalation in Ulcerative Colitis

Guest: Shail M. Govani, MD, MSc

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study.

Saartje Van de …

Tue 29 Jan 2019
Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance

Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance

Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance.

Liefferinckx C1, Minsart C, Toubeau JF, Cremer A, Amininejad L, Quertinmont E, Devière J, Gils A, van Gossum A, …
Tue 02 Jan 2018
Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance

Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance

Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance.

Liefferinckx C1, Minsart C, Toubeau JF, Cremer A, Amininejad L, Quertinmont E, Devière J, Gils A, van Gossum A, …
Tue 02 Jan 2018
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.

Vavricka SR1, Gubler M, Gantenbein C, Spoerri M, Froehlich F, Seibold F, Protic M, M…
Mon 30 Oct 2017
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.

Vavricka SR1, Gubler M, Gantenbein C, Spoerri M, Froehlich F, Seibold F, Protic M, M…
Mon 30 Oct 2017
Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy.

Sands BE1, Sandborn WJ, Van Assche G, Lukas M, X…

Thu 04 May 2017
Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy.

Sands BE1, Sandborn WJ, Van Assche G, Lukas M, X…

Thu 04 May 2017
Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-Based Study

Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-Based Study

Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-based Study

Nugent, Zoann PhD; Singh, Harminder MD, MPH; Targownik, Laura E. MD; Strome, Trevor MS; Sn…

Mon 27 Feb 2017
Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-Based Study

Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-Based Study

Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-based Study

Nugent, Zoann PhD; Singh, Harminder MD, MPH; Targownik, Laura E. MD; Strome, Trevor MS; Sn…

Mon 27 Feb 2017
Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations

Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations

Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations: A Cohort Study

Law, Cindy C. Y. MD; Sasidharan, Saranya MD; Rodrigues, Rodrigo MD; Nguyen, Deanna D. MD; Sauk, Jenny MD; …

Mon 31 Oct 2016
Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations

Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations

Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations: A Cohort Study

Law, Cindy C. Y. MD; Sasidharan, Saranya MD; Rodrigues, Rodrigo MD; Nguyen, Deanna D. MD; Sauk, Jenny MD; …

Mon 31 Oct 2016
Tissue-Specific Protein Clusters May Help Predict Risk of Alzheimer’s Disease

Tissue-Specific Protein Clusters May Help Predict Risk of Alzheimer’s Disease

A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer’s disease

Rosie Freer, Pietro Sormanni, Giulia Vecchi, Prajwal Ciryam, Christopher M. Dobson, and Mic…

Tue 25 Oct 2016
Tissue-Specific Protein Clusters May Help Predict Risk of Alzheimer’s Disease

Tissue-Specific Protein Clusters May Help Predict Risk of Alzheimer’s Disease

A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer’s disease

Rosie Freer, Pietro Sormanni, Giulia Vecchi, Prajwal Ciryam, Christopher M. Dobson, and Mic…

Tue 25 Oct 2016
Journal of Cystic Fibrosis: Microbial Colonization and Lung Function in Adolescents With Cystic Fibrosis

Journal of Cystic Fibrosis: Microbial Colonization and Lung Function in Adolescents With Cystic Fibrosis

Microbial colonization and lung function in adolescents with cystic fibrosis.

Hector A, Kirn T, Ralhan A, Graepler-Mainka U, Berenbrinker S, Riethmueller J, Hogardt M, Wagner M, Pfleger A, Autenrieth…

Mon 01 Aug 2016
Journal of Cystic Fibrosis: Microbial Colonization and Lung Function in Adolescents With Cystic Fibrosis

Journal of Cystic Fibrosis: Microbial Colonization and Lung Function in Adolescents With Cystic Fibrosis

Microbial colonization and lung function in adolescents with cystic fibrosis.

Hector A, Kirn T, Ralhan A, Graepler-Mainka U, Berenbrinker S, Riethmueller J, Hogardt M, Wagner M, Pfleger A, Autenrieth…

Mon 01 Aug 2016
Cell Death and Differentiation: A Novel Treatment of Cystic Fibrosis Acting On-Target

Cell Death and Differentiation: A Novel Treatment of Cystic Fibrosis Acting On-Target

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.

Tosco A, De Gregorio F, Esposito S, De Ste…

Mon 01 Aug 2016
Journal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients

Journal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis…

Mon 01 Aug 2016
Disclaimer: The podcast and artwork embedded on this page are the property of ReachMD. This content is not affiliated with or endorsed by eachpod.com.